Treatment effects and predictors of a 24-week course of interferon alpha-2b plus ribavirin combination therapy for patients with chronic hepatitis C-Reference-Cited by-同舟云学术

Treatment effects and predictors of a 24-week course of interferon alpha-2b plus ribavirin combination therapy for patients with chronic hepatitis C

Published:2006-07 Issue:7 Volume:21 Page:1177-1183
ISSN:0815-9319
Container-title:Journal of Gastroenterology and Hepatology
language:en
Short-container-title:J Gastroenterol Hepatol

Author:

Tomimatsu Masahiko,Aizawa Yoshio,Chuganji Yoshimichi,Ishizuka Hideo,Fujita Yoshiyuki,Aizawa Ryouichi,Abe Hiroshi,Matsuda Takako,Itou Yumi,Nakanishi Hiroyuki,Ushiyama Hisashi,Higuchi Teruhisa,Fujimoto Tomoko,Endou Hitoshi,Iga Daijiro,Ohta Kazuki,Kuroda Hiroyuki

Publisher

Wiley

Subject

Gastroenterology,Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1440-1746.2006.04311.x/fullpdf

Reference17 articles.

1. Hepatitis C virus antibody in patients with primary liver cancer (hepatocellular carcinoma, cholangiocarcinoma, and combined hepatocellular-cholangiocarcinoma) in Japan

2. Cost-effectiveness of interferon alfa 2b and ribavirin in the treatment of chronic hepatitis C

3. Interferon Alfa-2b Alone or in Combination with Ribavirin as Initial Treatment for Chronic Hepatitis C

4. Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hepatitis C virus (HCV) : Development of anti-HCV agents and anti-HCV therapy;Okayama Igakkai Zasshi (Journal of Okayama Medical Association);2020-12-01

2. Sustained Virological Response Rate and Host Background in Chronic Hepatitis C Patients Receiving Various Interferon Therapies;Inflammation and Regeneration;2007